Metformin improves lipid metabolism disorders through reducing the expression of microsomal triglyceride transfer protein in OLETF rats.

[1]  Mi Young Lee,et al.  Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy , 2016, Yonsei medical journal.

[2]  H. Sasaki,et al.  Hyperglycemia Enhances the Production of Amyloid β1-42 in the Lenses of Otsuka Long-Evans Tokushima Fatty Rats, a Model of Human Type 2 Diabetes. , 2016, Investigative ophthalmology & visual science.

[3]  F. Booth,et al.  Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats. , 2012, Journal of applied physiology.

[4]  T. Kuzuya,et al.  Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats. , 2012, Atherosclerosis.

[5]  S. Zeissig,et al.  Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice , 2012, Hepatology.

[6]  Fu-Bing Wang,et al.  HBV inhibits apoB production via the suppression of MTP expression , 2011, Lipids in Health and Disease.

[7]  A. Nishiyama,et al.  Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats. , 2011, Biochemical and biophysical research communications.

[8]  E. Kang,et al.  Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. , 2009, Metabolism: clinical and experimental.

[9]  M. Meseck,et al.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. , 2008, The Journal of clinical investigation.

[10]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[11]  S. Witting,et al.  Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the livers⃞ Published, JLR Papers in Press, April 21, 2007. , 2007, Journal of Lipid Research.

[12]  J. Altomonte,et al.  PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1 , 2007 .

[13]  D. Sullivan,et al.  A mild case of abetalipoproteinaemia in association with subclinical hypothyroidism , 2006, Annals of clinical biochemistry.

[14]  J. Borén,et al.  Adipocyte Differentiation-Related Protein Promotes Fatty Acid Storage in Cytosolic Triglycerides and Inhibits Secretion of Very Low–Density Lipoproteins , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Idf Clinical Guidelines Task Force.  Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[16]  S. Bertolini,et al.  Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. , 2005, Atherosclerosis.

[17]  T. Unterman,et al.  FoxO proteins in insulin action and metabolism , 2005, Trends in Endocrinology & Metabolism.

[18]  K. Adeli,et al.  Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance. , 2005, Biochemistry.

[19]  J. Xu,et al.  Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. , 2004, The Journal of clinical investigation.

[20]  K. Arden.  FoxO: linking new signaling pathways. , 2004, Molecular cell.

[21]  D. Accili,et al.  FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.

[22]  D. Accili,et al.  Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[23]  Roger A. Davis,et al.  Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER Published, JLR Papers in Press, February 16, 2003. DOI 10.1194/jlr.M300020-JLR200 , 2003, Journal of Lipid Research.

[24]  Marie C. M. Lin,et al.  Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. , 2003, Diabetes.

[25]  M. Hussain,et al.  Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.R200014-JLR200 , 2003, Journal of Lipid Research.

[26]  N. Borradaile,et al.  Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. , 2002, Journal of lipid research.

[27]  D. Accili,et al.  Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt. , 2001, Biochemistry.

[28]  S. Bertics,et al.  Changes in hepatic microsomal triglyceride transfer protein and triglyceride in periparturient dairy cattle. , 2000, Journal of dairy science.

[29]  J. Björkegren,et al.  A Deficiency of Microsomal Triglyceride Transfer Protein Reduces Apolipoprotein B Secretion* , 2000, The Journal of Biological Chemistry.

[30]  K. Kawano,et al.  Relationships between diet control and the development of spontaneous type II diabetes and diabetic nephropathy in OLETF rats. , 1996, Diabetes research and clinical practice.

[31]  A. Mizuno,et al.  Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? , 1995, Metabolism: clinical and experimental.

[32]  D. Peters,et al.  Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. , 1995, Drugs.

[33]  H. Jamil,et al.  Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. , 1994, The Journal of biological chemistry.

[34]  K. Kawano,et al.  Spontaneous Long-Term Hyperglycemic Rat With Diabetic Complications: Otsuka Long-Evans Tokushima Fatty (OLETF) Strain , 1992, Diabetes.

[35]  Guidelines Task Force Clinical.  Global guideline for type 2 diabetes , 2012 .

[36]  J. Altomonte,et al.  PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. , 2007, American journal of physiology. Endocrinology and metabolism.